Smith & Nephew revenue better than expected, but operating result disappoints
UK-based medtech firm Smith & Nephew, which competes with Coloplast, has reported a revenue that surpasses analysts' expectations, but the operating result is underwhelming.
BY RITZAU FINANS, TRANSLATED BY CATHERINE BRETT
Smith & Nephew, a UK-based company which makes products including bandages and creams, has released its half-year report for 2021.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
Coloplast sees potential in Russia
For subscribers
Sonova gains two new board members
For subscribers
.jpg&w=384&q=75)
